WBB Asset Management* leverages the proprietary research and analytics developed at the firm to identify and invest in emerging life science companies with potentially disruptive technologies. Investors in our strategies benefit from the knowledge and expertise we have gained over the decades as we utilize that investment acumen to identify new investment targets. The asset management division offers a series of strategies in the life sciences for potential institutional investors.
For more information, please contact us directly.
*WBB Asset Management is provided through WBB Securities LLC, a Registered Investment Advisor.